Irene González-Domínguez, PhD, is Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai. Her research focuses on the development of innovative preventive and therapeutic strategies against viral infections, with a particular emphasis on vaccine design and immunotherapeutics.
Over the past decade, Dr. González-Domínguez has built extensive expertise in the molecular design of virus-like particles (VLPs), the generation of viral vector vaccines (including NDV-based platforms), and the establishment of animal models to evaluate vaccine efficacy. Her current work targets high-priority areas such as universal influenza vaccines and therapeutic strategies for persistent SARS-CoV-2 infections in immunocompromised individuals. Dr. González-Domínguez earned her PhD in Biotechnology from the Autonomous University of Barcelona. She is inventor in multiple patents in vaccine innovation and has published extensively in high-impact journals such as Nature Communications, Molecular Therapy, Science Translational Medicine, and npj Vaccines.
Beyond the lab, she serves as the General Secretary of the Spanish Association of Scientists in the USA (ECUSA) and is an active mentor to the next generation of biomedical scientists.
